Patents by Inventor Shu Wakino

Shu Wakino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for treating chronic kidney disease
    Patent number: 10087449
    Abstract: This invention is related to a therapeutic agent for treating chronic kidney disease comprising a substance which inhibits the enzymatic activity of NNMT or suppresses NNMT gene expression, or a method for screening a therapeutic agent for treating chronic kidney disease which targets the NNMT enzyme or NNMT gene.
    Type: Grant
    Filed: April 6, 2015
    Date of Patent: October 2, 2018
    Assignees: SHIONOGI & CO., LTD., KEIO UNIVERSITY
    Inventors: Takashi Ono, Katsutoshi Yamada, Norito Yoshimura, Toshihiro Shinosaki, Yoshinari Gahara, Hiroshi Itoh, Shu Wakino, Takeshi Kanda, Kazuhiro Hasegawa, Motoaki Komatsu
  • PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC KIDNEY DISEASE
    Publication number: 20170107521
    Abstract: This invention is related to a therapeutic agent for treating chronic kidney disease comprising a substance which inhibits the enzymatic activity of NNMT or suppresses NNMT gene expression, or a method for screening a therapeutic agent for treating chronic kidney disease which targets the NNMT enzyme or NNMT gene.
    Type: Application
    Filed: April 6, 2015
    Publication date: April 20, 2017
    Applicants: SHIONOGI & CO., LTD., KEIO UNIVERSITY
    Inventors: Takashi ONO, Katsutoshi YAMADA, Norito YOSHIMURA, Toshihiro SHINOSAKI, Yoshinari GAHARA, Hiroshi ITOH, Shu WAKINO, Takeshi KANDA, Kazuhiro HASEGAWA, Motoaki KOMATSU
  • Antibody recognizing human 25-hydroxyvitamin D3-1a-hydroxylase
    Publication number: 20020031798
    Abstract: The present invention relates to a polypeptide having 25-hydroxyvitamin D3-1&agr;-hydroxylase activity, being useful for the prevention, diagnosis and therapeutic treatment of adult diseases such as osteoporosis induced by the decrease of active type vitamin D3 and catalyzing the final stage of vitamin D3 activation; and the gene encoding the polypeptide.
    Type: Application
    Filed: June 12, 2001
    Publication date: March 14, 2002
    Inventors: Hideharu Anazawa, Hiroko Shimada, Seiji Sugimoto, Tatsuo Suda, Toshimasa Shinki, Takao Saruta, Yuzuru Ishimura, Matsuhiko Hayashi, Shu Wakino, Toshiaki Monkawa, Tadashi Yoshida, Hiromichi Suzuki
  • 25-hydroxyvitamin D3-1&agr;-hydroxylase and DNA encoding the hydroxylase
    Patent number: 6274359
    Abstract: The present invention relates to a polypeptide having 25-hydroxyvitamin D3-1&agr;-hydroxylase activity, being useful for the prevention, diagnosis and therapeutic treatment of adult diseases such as osteoporosis induced by the decrease of active type vitamin D3 and catalyzing the final stage of vitamin D3 activation; and the gene encoding the polypeptide. In accordance with the present invention, the following can be provided; a polypeptide having 25-hydroxyvitamin D3-1&agr;-hydroxylase activity, DNA encoding the polypeptide, a recombinant DNA prepared by inserting the DNA in a vector, a transformant carrying the recombinant DNA, a method for preparing 25-hydroxyvitamin D3-1&agr;-hydroxylase by using the transformant, a method for preparing 1&agr;, 25-dihydroxyvitamin D3 comprising using the polypeptide having 25-hydroxyvitamin D3-1&agr;-hydroxylase activity, and an antibody recognizing the polypeptide.
    Type: Grant
    Filed: July 8, 1998
    Date of Patent: August 14, 2001
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Hideharu Anazawa, Hiroko Shimada, Seiji Sugimoto, Tatsuo Suda, Toshimasa Shinki, Takao Saruta, Yuzuru Ishimura, Matsuhiko Hayashi, Shu Wakino, Toshiaki Monkawa, Tadashi Yoshida, Hiromichi Suzuki